![Roy Whitfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy Whitfield
Director/Board Member at
NEKTAR THERAPEUTICS
Net worth: 1 M $ as of 2026-05-30
Profile
Roy A. Whitfield was the founder of Incyte Corp., established in 1991, where the title held was Director from 2003 to 2014.
The current job is Lead Independent Director at Nektar Therapeutics, starting in 2019 and ongoing since joining the company in 2000.
Former jobs include Executive Chairman at BioSeek, Inc.; Independent Director at Illumina, Inc. from 2011 to 2017; Director at Station X, Inc.; Director at Solexa, Inc. from 2006 to 2007; Director at Sciona, Inc.; Principal at The Boston Consulting Group, Inc.; Principal at Technicon Instruments Corp.
from 1984 to 1989; Principal at Cooper Biomedical, Inc.; and Advisor at InterWest Venture Management Co. Education includes an MBA from Stanford University and an undergraduate degree from the University of Oxford.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEKTAR THERAPEUTICS 0.06% | 2026-04-05 | 19,184 ( 0.06% ) | 1 M $ | 2026-05-30 |
Roy Whitfield active positions
| Companies | Position | Start |
|---|---|---|
| NEKTAR THERAPEUTICS | Director/Board Member | 2000-07-31 |
Former positions of Roy Whitfield
| Companies | Position | End |
|---|---|---|
| ILLUMINA, INC. | Director/Board Member | 2017-05-29 |
| INCYTE CORPORATION | Chief Executive Officer | 2001-10-31 |
Sciona, Inc.
 Sciona, Inc. Pharmaceuticals: MajorHealth Technology Provides health and nutrition recommendations | Director/Board Member | 2010-01-24 |
Interwest Venture Management Co.
 Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Corporate Officer/Principal | 2008-05-30 |
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Creates DNA cloning and analyses technologies | Director/Board Member | 2007-01-25 |
Training of Roy Whitfield
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Station X, Inc.
 Station X, Inc. Packaged SoftwareTechnology Services Develops software products for scientists and clinicians | Technology Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Creates DNA cloning and analyses technologies | Health Technology |
Sciona, Inc.
Sciona, Inc. Pharmaceuticals: MajorHealth Technology Provides health and nutrition recommendations | Health Technology |
BioSeek, Inc.
 BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services focusing on developing systems for the validation and development of novel human therapeutics | Commercial Services |
Technicon Instruments Corp. | |
Interwest Venture Management Co.
Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Finance |
Cooper Biomedical, Inc.
 Cooper Biomedical, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical devices | Health Technology |
- Stock Market
- Insiders
- Roy Whitfield
